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Summary
Bone morphogenetic proteins (BMPs) play essential roles in the control of skin development, postnatal tissue remodelling and
tumorigenesis. To explore whether some of the effects of BMP signalling are mediated by microRNAs, we performed genome-wide
microRNA (miRNA) screening in primary mouse keratinocytes after BMP4 treatment. Microarray analysis revealed substantial BMP4-
dependent changes in the expression of distinct miRNAs, including miR-21. Real-time PCR confirmed that BMP4 dramatically inhibits
miR-21 expression in the keratinocytes. Consistently, significantly increased levels of miR-21 were observed in transgenic mice
overexpressing the BMP antagonist noggin under control of the K14 promoter (K14-noggin). By in situ hybridization, miR-21
expression was observed in the epidermis and hair follicle epithelium in normal mouse skin. In K14-noggin skin, miR-21 was
prominently expressed in the epidermis, as well as in the peripheral portion of trichofolliculoma-like hair follicle-derived tumours that
contain proliferating and poorly differentiated cells. By transfecting keratinocytes with a miR-21 mimic, we identified the existence of
two groups of the BMP target genes, which are differentially regulated by miR-21. These included selected BMP-dependent tumour-
suppressor genes (Pten, Pdcd4, Timp3 and Tpm1) negatively regulated by miR-21, as well as miR-21-independent Id1, Id2, Id3 and
Msx2 that predominantly mediate the effects of BMPs on cell differentiation. In primary keratinocytes and HaCaT cells, miR-21
prevented the inhibitory effects of BMP4 on cell proliferation and migration. Thus, our study establishes a novel mechanism for the
regulation of BMP-induced effects in the skin and suggests miRNAs are important modulators of the effects of growth factor signalling
pathways on skin development and tumorigenesis.
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Introduction
Bone morphogenetic proteins (BMPs) belong to a large group of
secreted polypeptide growth factors that form the transforming
growth factor-b (TGF-b) superfamily. BMP signalling plays
essential roles in the control of organ development, postnatal
remodelling and regeneration by regulating proliferation,
differentiation and apoptosis in many cell types (Miyazono et
al., 2010; Walsh et al., 2010). During skin development, BMP
signalling controls the initiation phase of hair follicle (HF)
morphogenesis, as well as being required for a proper control of
keratinocyte differentiation in the HF and epidermis (Botchkarev
et al., 1999; Kobielak et al., 2003; Sharov et al., 2003; Andl et al.,
2004; Guha et al., 2004). In adult skin, BMP signalling is also
involved in the control of HF cycling, HF size and hair
pigmentation (Sharov et al., 2006; Sharov et al., 2009).
Furthermore, BMP signalling operates as a potent tumour
suppressor in the skin and inhibits formation of epidermal- and
HF-derived tumours (Blessing et al., 1995; Sharov et al., 2009).
MicroRNAs (miRNA) are a large family of regulatory
molecules found in all multicellular organisms. MiRNAs are
small non-coding RNAs of approximately 22 nucleotides in
length that are created by the enzymatic cleavage of the
endogenous primary transcript that contains a local hairpin
structure (Ambros, 2001; Bartel, 2004; Farajollahi and Maas,
2010). Currently, it is estimated that miRNA genes make up
approximately 3% of the known genes, and up to 30% of genes
might be regulated by miRNAs in eukaryotes. MiRNAs regulate
gene expression at the post-transcriptional level by forming the
Watson–Crick base pairs between its seed region and miRNA
recognition elements in the target mRNA 39 UTRs (Brennecke et
al., 2005).
The expression pattern of miRNAs is tissue- and
developmental stage-specific. Recently, miR-203 was identified
as a skin-specific miRNA that targets the p63 transcription factor
in the developing epidermis, restricts keratinocyte proliferation
and induces differentiation (Lena et al., 2008; Yi et al., 2008).
We demonstrated that in postnatal skin, miRNAs are
differentially expressed during distinct stages of the hair cycle
(Mardaryev et al., 2010). In particular, miR-31 is highly
expressed in actively growing HFs, and, by targeting a number
of growth regulatory molecules and cytoskeletal proteins, is
involved in establishing an optimal balance of gene expression
required for proper HF growth and hair fibre formation
(Mardaryev et al., 2010).
Increasing evidence suggests that the misexpression of
miRNAs is associated with alterations in the cellular signalling
networks and gene expression profiles, and leads to the



















abnormal hair growth, inflammatory skin diseases and
tumorigenesis (Andl et al., 2006; Sonkoly and Pivarcsi, 2009;
Yi and Fuchs, 2010). However, the mechanisms underlying the
cross-talk between individual miRNAs and the activity of
signalling pathways that control keratinocyte proliferation and
differentiation in normal skin and during tumorigenesis remain
largely unknown. In this study, we identify the profile of
miRNAs the expression of which is modulated by BMP
signalling in primary epidermal keratinocytes. Specifically, we
show that miR-21 expression in keratinocytes is negatively
regulated by BMP4. In turn, miR-21 might inhibit the anti-
tumour activity of BMPs in the skin by targeting a number of the
BMP-regulated tumour-suppressor genes.
Results and Discussion
BMP4 induces changes in the expression of distinct
miRNAs in primary mouse keratinocytes
To define whether BMP4 treatment of primary mouse epidermal
keratinocytes leads to changes in their global miRNA signature,
cells isolated from 2- to 3-day-old mice were treated with BMP4
for 4 hours and miRNA expression profiling was performed
using microarray analysis, as described previously (Mardaryev et
al., 2010). Global miRNA microarray analysis revealed that 13
out of 226 miRNAs analyzed showed significant (P,0.01)
twofold and higher changes in their expression in response to
BMP4 treatment (Fig. 1A,B).
The function of the majority of miRNAs, whose expression in
keratinocytes was either positively or negatively regulated by
BMP4, has not been identified yet. Among those miRNAs, miR-
21 showed very high basal expression levels in keratinocytes (i.e.
10- to 20-fold higher than other miRNAs), which was markedly
decreased in response to BMP4 treatment (Fig. 1B). Quantitative
RT-PCR (qRT-PCR) analysis confirmed that BMP4 significantly
(P,0.01) inhibited miR-21 expression in mouse primary
keratinocytes, as well as in HaCaT cells (Fig. 1C,D). However,
the levels of primary miR-21 and precursor miR-21 (pri-miR-21
and pre-miR-21, respectively) transcripts in the keratinocytes
remained unchanged (data not shown). It was previously shown
that BMP signalling can differentially influence miR-21
biogenesis in distinct cell types (Davis et al., 2008; Du et al.,
2009; Sahni et al., 2010). Our data suggest that BMP4 negatively
regulates the expression of miR-21 post-transcriptionally,
Fig. 1. miRNA expression profile of mouse primary keratinocytes treated with BMP4. (A,B) Microarray analysis. (A) A heat map depicting the miRNAs for
which the expression significantly (P,0.01) changed after BMP4 treatment; red and green colours represent elevated and decreased expression of miRNAs,
respectively. (B) Table of miRNAs showing >2-fold or higher changes in expression in the keratinocytes treated with BMP4 (levels of expression are shown in
arbitrary units). (C,D) Detection of miR-21 by qRT-PCR. BMP4 treatment significantly (*P,0.01) reduced expression of the mature form of miR-21 in the
primary mouse epidermal keratinocytes (PMK; C) and HaCaT cells (D).


















affecting the cytoplasmic processing of pre-miR-21 to mature
miR-21 in the keratinocytes, which is consistent with data
obtained from astrocytes (Sahni et al., 2010).
miR-21 is expressed in the epidermis and hair follicle and
is increased in the skin of K14-noggin transgenic mice
Recent reports have identified miR-21 as a unique miRNA that is
consistently overexpressed in a number of tumours, including
melanoma and squamous cell carcinoma (Krichevsky and
Gabriely, 2009; Selcuklu et al., 2009; Dziunycz et al., 2010).
However, the spatiotemporal expression of miR-21 in normal
skin has not yet been elucidated. By in situ hybridisation, miR-21
expression was seen in the basal and suprabasal layers of the
epidermis of 12-week-old wild-type mice, but was not detected in
the dermis (Fig. 2A). In addition, prominent miR-21 expression
was seen in the HF outer and inner root sheaths and in the hair
matrix, but not in the follicular papilla (Fig. 2A).
BMP signalling suppresses the development of epithelial
tumours in the chemical skin carcinogenesis model (Blessing et
al., 1995), whereas BMP anti-tumour activity is compromised by
extracellular BMP antagonists such as noggin and gremlin
(Sneddon et al., 2006; Sharov et al., 2009). To define whether
deficiency of BMP signalling affects miR-21 expression, we
analyzed its expression in the skin of transgenic mice in which
noggin was expressed under the K14 promoter (K14-noggin),
which are characterized by spontaneous development of HF-
derived trichofolliculoma-like tumours (Sharov et al., 2009). In
K14-noggin skin, prominent miR-21 expression was seen in the
epidermis, whereas in the HF-derived tumours miR-21 was
expressed predominantly in their peripheral portion that contains
proliferating and partially differentiated cells (Fig. 2B) (Sharov
et al., 2009). The in situ hybridization data (Fig. 2B) were
confirmed by qRT-PCR analysis that showed significantly
(P,0.01) higher levels of miR-21 in the total skin of K14-
noggin mice compared with wild-type mice (Fig. 2C).
These results are consistent with data demonstrating inhibitory
effects of BMP4 on miR-21 expression in the keratinocytes
(Fig. 1), as well as with recent findings showing that BMP6
causes post-transcriptional repression of miR-21 in breast cancer
cells (Du et al., 2009). Because miR-21 functions are generally
considered as pro-carcinogenic and associated with tumour
progression and metastasis (Krichevsky and Gabriely, 2009),
negative regulation of miR-21 by the BMP signalling identified
here suggests a novel mechanism, which might mediate anti-
tumour activity of BMP signalling in the skin.
miR-21 differentially regulates expression of the BMP
target genes and modulates effects of BMP-4 on cell
proliferation and migration
BMP signalling regulates expression of a large number of genes
in keratinocytes (Fessing et al., 2010), and some of them (such as
Pdcd4, Pten, Timp3 and Tpm1) also serve as direct targets of
miR-21 in other cell types (Zhu et al., 2007; Asangani et al.,
2008; Song et al., 2010; Zhang et al., 2010). To explore whether
miR-21 is indeed involved in the regulation of the BMP-
dependent gene expression program in keratinocytes, primary
epidermal keratinocytes were treated with BMP4 or an miR-21
mimic (pro-miR-21) and the corresponding controls. The
expression of the selected BMP target genes (Id1, Id2 Id3,
Msx2, Pten, Pdcd4, Timp3 and Tpm1) known to mediate the
effects of BMP in different cell types including keratinocytes
(Ogata et al., 1993; Hussein et al., 2003; Fessing et al., 2010) was
assessed by qRT-PCR.
In agreement with data published previously (Fessing et al.,
2010), treatment of the keratinocytes with BMP4 resulted in a
marked increase in the mRNA levels of all BMP target genes
selected for analyses, compared with the controls (Fig. 3A,B).
However, miR-21 treatment alone differentially modulated the
expression of those genes that were positively regulated by BMP4
in keratinocytes. The levels of transcripts of some BMP target
genes (Id1, Id2 Id3 and Msx2) were the same in the keratinocytes
transfected with pro-miR-21 as in the controls (Fig. 3C). However,
pro-miR-21 caused significant (P,0.01) downregulation of the
expression of Pten, Pdcd4, Timp3 and Tpm1 in keratinocytes
versus the controls (Fig. 3D). To determine whether miR-21 could
prevent the BMP4-induced increased expression of these genes,
primary mouse keratinocytes and HaCaT cells were first
transfected with the miR-21 mimic and then treated with BMP4.
Pretreatment of the keratinocytes with pro-miR-21 resulted in the
failure of BMP4 to increase the mRNA levels of Pten, Pdcd4,
Timp3 and Tpm1, compared with the BMP4 treatment alone
(Fig. 3E). Similar changes in gene expression were seen in the
HaCaT keratinocytes (data not shown). Consistent with these
results, significantly (P,0.01) decreased levels of Pten, Pdcd4,
Timp3 and Tpm1 transcripts were found in skin of K14-noggin
mice compared with wild-type skin (Fig. 3F).
Fig. 2. Spatiotemporal expression of miR-21 in the skin. (A,B) Representative photomicrographs of in situ hybridization for miR-21. (A) miR-21 expression in
the basal and suprabasal layers of the epidermis (arrowheads), in the HF outer and inner root sheaths (large and small arrows, respectively) and in the hair matrix
(asterisk) in the skin of a 12-week-old wild-type mouse. (B) Prominent miR-21 expression in the epidermis (arrowheads) and in the periphery of the tumours
(arrows) in K14-noggin skin. (C) Detection of miR-21 by qRT-PCR: there were significantly (*P,0.01) increased levels of miR-21 in the total skin of K14-
noggin mice than in wild-type mice.


















These data therefore suggest that miR-21 is indeed involved in
mediating the effects of BMP signalling in keratinocytes by
modulating the expression of selected BMP target genes that also
serve as miR-21 targets. Although the full profile of the miR-21
target mRNAs in keratinocytes remains to be defined, some of
the genes that in keratinocytes are regulated by both BMP4 and
miR-21 (Pten, Pdcd4, Timp3 and Tpm1) serve as tumour
suppressors in many organs and cell types (Zhu et al., 2007;
Fig. 3. miR-21 modulates the effects of BMP4 on gene expression, cell proliferation and migration in keratinocytes. (A–E) qRT-PCR analysis of gene
expression in the primary mouse keratinocytes relatively to Gapdh levels. (A) BMP4 treatment causes a significant increase in the expression of Id1, Id2, Id3 and
Msx2 compared with untreated cells. (B) Upregulation in the expression of Pdcd4, Pten, Timp3 and Tpm1 transcripts by BMP4 treatment. (C) Expression of Id1,
Id2, Id3 and Msx2 is not affected by transfection with miR-21 mimic (pro-miR-21). (D) Expression of Pdcd4, Pten, Timp3 and Tpm1 is decreased after treatment
with miR-21 mimic. (E) miR-21 mimic prevents BMP4-induced expression of Pdcd4, Pten, Timp3 and Tpm1 in keratinocytes. (F) Expression of Pten, Pdcd4,
Timp3 and Tpm1 in the skin of K14-noggin transgenic mice is decreased compared with wild-type mice. (G) Flow cytometry analysis of the cell cycle in primary
keratinocytes: a significant decrease in number of proliferating cells caused by BMP-4 treatment was prevented by the miR-21 mimic. (H) Cell migration (scratch)
assay. miR-21 mimic significantly increases HaCaT cell migration compared with the control, and interferes with the suppression of cell migration induced by
BMP4; *P,0.01, **P,0.001.


















Asangani et al., 2008; Song et al., 2010; Zhang et al., 2010). Loss
of PTEN expression in the skin contributes to tumour
development (reviewed by Ming and He, 2009), whereas
transgenic overexpression of Pdcd4 in the epidermis causes an
inhibition of tumour growth in chemical skin carcinogenesis tests
(Jansen et al., 2005). TIMP3 and TPM1 also suppress tumour
growth by regulating epithelial–mesenchymal interactions and
inhibiting cell motility and tumour invasion (Zheng et al., 2008;
Rodgers et al., 2009).
To determine whether miR-21 is indeed capable of interfering
with the inhibitory effects of BMP on keratinocyte proliferation
and motility, cell cycle and in vitro ‘scratch’ migration assays
were performed using primary keratinocytes and HaCaT cells,
respectively. Consistent with data published previously (Sharov
et al., 2006), BMP4 significantly (P,0.05) inhibited cell
proliferation in primary keratinocytes (Fig. 3G). Pro-miR-21
treatment alone did not alter keratinocyte proliferation, but
significantly (P,0.05) diminished the anti-proliferative effects of
BMP4 on these cells (Fig. 3G). The scratch assay revealed that
miR-21 mimic significantly (P,0.01) accelerated migration of
HaCaT cell compared with the control, as well as preventing the
inhibitory effects of BMP4 on the motility of HaCaT cells
(Fig. 3H).
Thus, BMP signalling might have an anti-tumour functions in
the skin in part by downregulating miR-21 expression and
thereby removing its negative effects on the expression of Pten,
Pdcd4, Timp3 and Tpm1 as tumour suppressor genes. Our data
also demonstrate that miR-21 does not interfere with BMP4-
induced expression of Id1, Id2, Id3 and Msx2 in the keratinocytes
(Fig. 3C). Id1–3 are established targets for BMP signalling, and
they mediate its effect on cell differentiation (Langlands et al.,
2000; Sharov et al., 2003). Msx2 also mediates the effects of
BMP signalling during skin development and in postnatal hair
follicles, as well as contributing to re-epithelialisation in the
epidermis (Yeh et al., 2009). This suggests that the effects of
BMP on cell differentiation are likely to occur in an miR-21-
independent manner.
Taken together, we identified the existence of two groups of
BMP target genes, the expressions of which are differentially
regulated by miR-21. BMP-dependent tumour-suppressor genes
such as Pten, Pdcd4, Timp3 and Tpm1 are negatively regulated
by miR-21, whereas Id1, Id2, Id3 and Msx2, which
predominantly mediate the effects of BMPs on cell
differentiation, are miR-21 independent (Fig. 4). Although
additional studies are required to fully elucidate how BMP
signalling controls miR-21 expression in keratinocytes, our data
reveal miR-21 as an important downstream component that
modulates the BMP-regulated gene expression program and its
effects on the distinct groups of target genes. In conclusion, our
study establishes a novel mechanism for the regulation of BMP-
induced effects in the skin and suggests that, together with the
BMP target genes described previously (Fessing et al., 2010),
BMP signalling also exerts its effects on keratinocytes through




Primary mouse epidermal keratinocytes (PMEKs) were prepared from newborn
mice at postnatal days 2–3, as described previously (Lichti et al., 2008). HaCaT
keratinocytes were grown in Dulbecco’s modified Eagle’s medium (Invitrogen,
UK) supplemented with heat-inactivated 10% foetal bovine serum. PMEKs and
HaCaT were treated with 200 ng/ml of recombinant human BMP4 (98% identity
with mouse Bmp4 protein; R&D system, UK) for 4 and 12 hours as described
previously (Fessing et al., 2010). Cells were transfected with 200 nM miR-21
mimic (pro-miR-21) or miRNA negative controls (Dharmacon, USA), using
Lipofectamine RNAiMax (Invitrogen, UK), and harvested 24 hours later. To
examine the regulatory effects of miR-21 on BMP-induced gene expression,
keratinocytes were transfected with 200 nM synthetic pro-miR-21 or miRNA
negative controls for 4 hours, followed by quick washing in PBS and treatment
with 200 ng/ml of BMP4 for 4 hours.
Animals and tissue collection
All animal work was performed under local research ethics committee approval.
K14-noggin-overexpressing mice were generated in an FVB background as
described previously (Sharov et al., 2009). Skin samples were collected from adult
mice (12-weeks old, n55 for each mouse strain) and processed for further analyses
as described elsewhere (Mardaryev et al., 2010).
Microarray and real-time PCR
Total RNA was isolated using the miRNeasy kit (Qiagen, UK). Microarray
analysis was performed by LC Sciences (Houston, TX). qRT-PCR for miR-21 was
performed using TaqManH Real Time PCR Assay (Applied Biosystems, USA).
Differences between samples and controls were calculated based on the Ct (DDCt)
method and normalized to the small nucleolar RNA 202 values (SnoRNA). Data
were pooled, the means ¡ s.e.m. were calculated, and statistical analysis was
performed using an unpaired Student’s t-test. qRT-PCR for mRNAs was
performed as described previously using Gapdh as an internal control
(Mardaryev et al., 2010). PCR primers were designed on Beacon Designer
software (Premier Biosoft, Palo Alto, CA; supplementary material Table S1).
In situ hybridization
Skin cryosections (10 mm) were fixed in 4% paraformaldehyde for 10 minutes at
room temperature (RT). After acetylation in triethanolamine buffer (4.5 mM
triethanolamine, 6 M HCl, 3 mM acetic anhydride) for 10 minutes and pre-
mobilisation (1% Triton X-100 in 16 PBS) for 30 minutes, slides were hybridized
with 2.5 pmol digoxigenin-labelled miR-21 probe (Exiqon, Vedbaek, Denmark)
diluted in hybridization buffer (50% formamide DI, 26 SCC, 1% dextran
sulphate, 0.4 mg/ml tRNA) for 16–18 hours at 55 C˚. Slides were then washed in
26 SCC (10 minutes, four times, 67 C˚), 0.16 SCC (60 minutes, 65 C˚) and 0.26
SCC (10 minutes, RT). Immunodetection of miR-21 was performed with sheep
alkaline-phosphatase-conjugated anti-digoxigenin antibody (1:5000; Roche,
Germany) followed by a staining reaction with nitro-blue tetrazolium and 5-
bromo-4-chloro-39-indolyphosphate (NBT/BCIP) solution (Roche, Germany) for
16–18 hours at RT.
Flow cytometry
To assess proliferation rate, cells were washed with PBS and fixed in 70% ethanol
followed by incubation with 20 mg/ml of 7-aminoactinomycin D (VWR,
Lutterworth, UK) for 15 minutes at RT. The percentage of cells at distinct
phases of the cell cycle was analysed by flow cytometry with a Beckman Coulter –
CyAn2 ADP analyser (Beckman Coulter, UK) equipped with Summit2
Software, version 4.2. For each sample, 10,000 events were collected.
Fig. 4. Schematic illustrating an involvement of miR-21 in the
modulation of BMP4-mediated effects on gene expression in
keratinocytes. miR-21 modulates the BMP anti-tumour activity by negative
regulation of the expression of BMP-dependent tumour-suppressor genes
(Pten, Pdcd4, Timp3 and Tpm1) in keratinocytes. However, the effects of
BMP on keratinocyte differentiation mediated through its targets Id1, Id2, Id3
and Msx2 are miR-21 independent.



















HaCaT cells were treated as described above. Using a P10 pipette tip, a scratch was
made in the middle of the plate. Mitomycin C (2 mg/ml; VWR, UK) was included
in the migration assay to block cell proliferation. The distance between the leading
edges of the migrating keratinocytes was measured using ImageJ software (http://
rsbweb.nih.gov/ij/), as described previously (Chmielowiec et al., 2007). Data from
triplicate samples were pooled, the means ¡ s.d. were calculated, and statistical
analysis was performed using an unpaired Student’s t-test.
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